Pale Fire Capital SE Takes Position in Prelude Therapeutics Incorporated (NASDAQ:PRLD) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Prelude Therapeutics Incorporated (NASDAQ:PRLD – Get Free Report) was the target of a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 522,000 shares, an increase of 15.6% from the January 15th total of 451,500 shares. Based on an average trading volume of 141,000 shares, […]
WILMINGTON, Del., Dec. 11, 2023 Prelude Therapeutics Incorporated , a clinical-stage precision oncology company, today announced a private placement that the Company estimates will result in.
Prelude Therapeutics Announces $25 Million Private Placement streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.